MedPath

Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.

Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
First Posted Date
2007-05-24
Last Posted Date
2011-08-31
Lead Sponsor
Mayo Clinic
Target Recruit Count
53
Registration Number
NCT00478218
Locations
🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

🇺🇸

Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma

First Posted Date
2007-05-23
Last Posted Date
2022-01-28
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
107
Registration Number
NCT00477412
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications

Not Applicable
Completed
Conditions
Uveitis
Iritis
Iridocyclitis
Anterior Uveitis
Macular Edema
Interventions
First Posted Date
2007-05-22
Last Posted Date
2017-05-01
Lead Sponsor
Norwegian University of Science and Technology
Target Recruit Count
218
Registration Number
NCT00476593
Locations
🇳🇴

Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway

🇳🇴

Department of Ophthalmology, St Olavs University Hospital, Trondheim, Norway

ALL Adult Consortium Trial: Adult ALL Trial

First Posted Date
2007-05-21
Last Posted Date
2024-04-17
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
112
Registration Number
NCT00476190
Locations
🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Children's Hospital of Boston, Boston, Massachusetts, United States

and more 12 locations

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

First Posted Date
2007-05-17
Last Posted Date
2015-11-10
Lead Sponsor
Joseph Roscoe
Target Recruit Count
1021
Registration Number
NCT00475085
Locations
🇺🇸

MBCCOP - Gulf Coast, Mobile, Alabama, United States

🇺🇸

CCOP - Central Illinois, Decatur, Illinois, United States

🇺🇸

CCOP - Kalamazoo, Kalamazoo, Michigan, United States

and more 13 locations

A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 2
Terminated
Conditions
Diffuse Large B-cell Lymphoma
Interventions
Drug: CC-5013 (lenalidomide)
Drug: dexamethasone
First Posted Date
2007-05-16
Last Posted Date
2009-09-02
Lead Sponsor
Celgene Corporation
Target Recruit Count
26
Registration Number
NCT00474188
Locations
🇺🇸

Washington County Hospital, The Center for Clinical Research, Hagerstown, Maryland, United States

🇺🇸

Oncology & Hematology Specialists, PA, Denville, New Jersey, United States

🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 21 locations

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Phase 1
Completed
Conditions
Prostatic Neoplasms
Interventions
First Posted Date
2007-05-15
Last Posted Date
2014-03-27
Lead Sponsor
Cougar Biotechnology, Inc.
Target Recruit Count
54
Registration Number
NCT00473512

Dexamethasone Infusion in Community-acquired Pneumonia

Not Applicable
Completed
Conditions
Pneumonia
Interventions
First Posted Date
2007-05-10
Last Posted Date
2010-09-27
Lead Sponsor
St. Antonius Hospital
Target Recruit Count
300
Registration Number
NCT00471640
Locations
🇳🇱

St Antonius Hosptial, Nieuwegein, Utrecht, Netherlands

🇳🇱

Gelderse Vallei Ede, Ede, Gelderland, Netherlands

Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema

Phase 2
Completed
Conditions
Diabetic Macular Edema
Interventions
Drug: Sham injection
Drug: Dexamethasone
Procedure: Laser Photocoagulation
First Posted Date
2007-04-24
Last Posted Date
2019-04-24
Lead Sponsor
Allergan
Target Recruit Count
253
Registration Number
NCT00464685

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia

First Posted Date
2007-04-19
Last Posted Date
2013-11-14
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
23
Registration Number
NCT00462787
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath